HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

Abstract
It has not been firmly established whether disturbed calcium-phosphate metabolism affects progression of chronic kidney disease (CKD) in humans. In this cohort study of 227 nondiabetic patients with CKD, we assessed fibroblast growth factor 23 (FGF23) plasma concentrations in addition to other variables involved in calcium-phosphate metabolism, and we followed 177 of the patients prospectively for a median of 53 months to assess progression of renal disease. In the baseline cohort, we found a significant inverse correlation between glomerular filtration rate and both c-terminal and intact FGF23 levels (both P < 0.001). The 65 patients who experienced a doubling of serum creatinine and/or terminal renal failure were significantly older, had a significantly lower glomerular filtration rate at baseline, and significantly higher levels of intact parathormone, c-terminal and intact FGF23, and serum phosphate (all P < 0.001). Cox regression analysis revealed that both c-terminal and intact FGF23 independently predict progression of CKD after adjustment for age, gender, GFR, proteinuria, and serum levels of calcium, phosphate, and parathyroid hormone. The mean follow-up time to a progression end point was 46.9 (95% CI 40.2 to 53.6) months versus 72.5 (95% CI 67.7 to 77.3) months for patients with c-terminal FGF23 levels above or below the optimal cut-off level of 104 rU/mL (derived by receiver operator curve analysis), respectively. In conclusion, FGF23 is a novel independent predictor of progression of renal disease in patients with nondiabetic CKD. Its pathophysiological significance remains to be elucidated.
AuthorsDanilo Fliser, Barbara Kollerits, Ulrich Neyer, Donna P Ankerst, Karl Lhotta, Arno Lingenhel, Eberhard Ritz, Florian Kronenberg, MMKD Study Group, Erich Kuen, Paul König, Günter Kraatz, Johannes F E Mann, Gerhard A Müller, Hans Köhler, Peter Riegler
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 18 Issue 9 Pg. 2600-8 (Sep 2007) ISSN: 1046-6673 [Print] United States
PMID17656479 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FGF23 protein, human
  • Phosphates
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Creatinine
  • Calcium
Topics
  • Adult
  • Age Factors
  • Calcium (metabolism)
  • Chronic Disease
  • Cohort Studies
  • Creatinine (blood)
  • Disease Progression
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors (blood, chemistry)
  • Glomerular Filtration Rate
  • Humans
  • Kidney Diseases (blood, complications, metabolism, physiopathology)
  • Male
  • Middle Aged
  • Phosphates (metabolism)
  • Predictive Value of Tests
  • Prospective Studies
  • Renal Insufficiency (etiology)
  • Terminally Ill

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: